Marshall Wace
PEARW

Marshall Wace’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Marshall Wace’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300,000
Closed -$462K – 3965
2022
Q2 		$462K Sell
300,000
-27,171
-8% -$13.4K ﹤0.01% 2823
2022
Q1 		$1.65M Sell
327,171
-15,062
-4% -$10.5K ﹤0.01% 2173
2021
Q4 		$2.12M Buy
342,233
+126,400
+59% +$128K ﹤0.01% 2003
2021
Q3 		$2.15M Buy
215,833
+32,437
+18% +$33.8K 0.01% 1492
2021
Q2 		$1.81M Buy
+183,396
New +$160K 0.01% 1481

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return